Skip to main content

Optimization of Drug Anchor for Ortho-Carborane in Reconstitution of Low Density Lipoproteins for Neutron Capture Therapy

  • Chapter
Cancer Neutron Capture Therapy

Abstract

Low density lipoproteins (LDL) have considerable potential as carriers for site-specific drug delivery.1 The core of native LDL is composed mainly of cholesteryl esters of long chain unsaturated fatty acids, which can be removed and replaced with other hydrophobic compounds. These core compounds can be regarded as specific combinations of structural units that not only provide efficient packing in the core environment, but also enhance passage through the phospholipid coat into the core. For example, it has been demonstrated that esters of unsaturated fatty acids are incorporated into heptane-extracted LDL far more effectively than esters of the corresponding saturated fatty acids.2 The aim of the present study, which is an extension of the pioneering work of Kahl et a1,3–7 is to find which combination of these structural elements forms the best drug anchor for delivery of o-carborane to a tumour in reconstituted LDL.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. P. C. de Smidt & Th. J. C. van Berkel, LDL-Mediated drug targeting, Critical Reviews in Therapeutic Drug Carrier Systems, 7: 99–120, 1990.

    PubMed  Google Scholar 

  2. M. Krieger, M. J. McPhaul, J. L. Goldstein, M. S. Brown, Replacement of neutral lipids of low density lipoprotein with esters of long chain unsaturated fatty acids, J. Biol. Chem., 254: 3845–3853, 1979.

    PubMed  CAS  Google Scholar 

  3. Stephen B. Kahl, Tumor-specific targeting of third generation boron compounds: recent experience with porphyrins, low density lipoproteins and amino acids, in: “Boron Compounds suitable for NCT for the treatment of Cancer”, National Cancer Institute, Bethesda, MD, 1988.

    Google Scholar 

  4. S. B. Kahl, J. C. Callaway, New tumor localizers: advances in the use of low density lipoproteins (LDL), StrahlentherOnkol., 165: 137–139, 1989.

    CAS  Google Scholar 

  5. S. B. Kahl, D. Pate, B. H. Laster, E. A. Popenoe, R. G. Fairchild, In vitro biological efficacy of boronated low density lipoproteins for NCT, in: “Progress in Neutron Capture Therapy for Cancer”, Ed. B. J. Allen, D.E. Moore and B.V. Harrington, Plenum Press, New York, 1992, pp 365–368.

    Chapter  Google Scholar 

  6. S.B. Kahl and D. W. Pate, Low density lipoprotein reconstitutions with alkyl and aryl carboranes, in: “Advances in Neutron Capture Therapy”, Ed. A.H. Soloway, R.F. Barth and D.E. Carpenter, Plenum Press, New York, 1993, pp 399–402.

    Chapter  Google Scholar 

  7. S. Kahl, Reconstitution of low density lipoproteins with carborane compounds, in: INEL BNCT Research Program Annual Report 1992, Idaho National Engineering Laboratory, Idaho Falls, Idaho, 1993, pp 5–11.

    Google Scholar 

  8. R. J. Deckelbaum, G. G. Shipley, D. M. Small, Structure and interactions of lipids in human plasma low density lipoproteins, J. Biol. Chem., 252: 744–754, 1977.

    PubMed  CAS  Google Scholar 

  9. R. N. Grimes, “Carboranes”, Academic Press, New York, 1970.

    Google Scholar 

  10. M. M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochern., 72: 248–254, 1976.

    Article  CAS  Google Scholar 

  11. Y. Setiawan, M. D. Smith, D.E. Moore, B. J. Allen, Pharmacokinetics and neutron capture therapy of melanoma xenografts using boronated low density lipoprotein. (these proceedings)

    Google Scholar 

  12. Y. Setiawan, T. Rise, D. E. Moore, Fourier transform infrared (FTIR) spectrometry for the assay of polyhedral boron compounds in plasma and pharmaceutical formulations, Pharm. Res., 11: 723–727, 1994.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer Science+Business Media New York

About this chapter

Cite this chapter

Smith, M.D., Setiawan, Y., Moore, D.E. (1996). Optimization of Drug Anchor for Ortho-Carborane in Reconstitution of Low Density Lipoproteins for Neutron Capture Therapy. In: Mishima, Y. (eds) Cancer Neutron Capture Therapy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9567-7_19

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-9567-7_19

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4757-9569-1

  • Online ISBN: 978-1-4757-9567-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics